Tracking the CRBP option chain helps you see every strike and expiry on Corbus Pharmaceuticals Holdings Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Corbus Pharmaceuticals Holdings Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRBP options activity at a glance. Use our scanner to monitor the CRBP option chain in real time and filter for the CRBP options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRBP stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CRBP option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CRBP stock options are being actively traded and where they are not.
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the activation of transforming growth factor ß (TGFß); and CRB-602, an anti-avß6/avß8 mAb that blocks the activation of TGFß for the treatment of fibrotic diseases.
The company is also developing cannabinoid receptor type 1 inverse agonist program for the treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; fibrotic diseases, including lung, cardiac, renal disease, and liver fibrosis; and other diseases comprising ascites, cognitive defects, Prader-Willi syndrome, and smoking cessation. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Corbus Pharmaceuticals Holdings Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CRBP options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CRBP stock options — let the full option chain come to you, pre-filtered and ready to trade.
